DiaSorin has received FDA clearance for its Liaison direct renin immunoassay to aid in the diagnosis and treatment of certain types of hypertension.
The renin immunoassay is performed on the company’s automated random-access Liaison platform and provides rapid results. Laboratories will benefit from high throughput and complete walkaway automation, with excellent precision and sensitivity.
DiaSorin, 631-351-5701